
Cora Health Review
Best for: flat-rate compounded GLP-1 from $99/mo with named pharmacy disclosure
Cora Health is one of the most affordable GLP-1 options on the market.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Cora Health is a direct-to-consumer telehealth platform offering compounded semaglutide ($99–$175/mo) and tirzepatide ($135–$225/mo) with flat per-tier pricing — no surcharge as your dose escalates. It names its 503A compounding pharmacy partners — PCAB-accredited Hallandale Pharmacy and VialsRx — which is unusual for the segment, and it is LegitScript Certified (ID 49690100). Available in all 50 states with no membership fee; HSA/FSA accepted, and an annual commitment drops semaglutide to $99/mo.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Top-rated alternatives to Cora Health
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Cora Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $99/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Cora Health
Each dimension is scored algorithmically from Cora Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.7/10At $99/mo, Cora Health runs about 41% below the $169 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.5/10Cora Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.8/10Online intake and platform experience — consult included in the price; 7 platform features disclosed.
Trust & Safety15%
7.4/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-07-10).
Accessibility10%
8.1/10Cora Health treats patients in all 50 states. FSA/HSA cards are accepted.
Support10%
5.3/10Cora Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Cora Health review
Last checked July 2026- Confirmed current pricing across 8 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with Cora Health
We walked Cora Health’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a quick questionnaire (about 5 minutes).
- 2A board-certified provider reviews it (in under 24 hours).
- 3If approved, compounded semaglutide or tirzepatide is prescribed.
- 4Medication ships to your door in under 3 days with ongoing support.
- Transparent all-inclusive pricing shown before signup: semaglutide $99-$175/month, tirzepatide $135-$225/month.
- Free discreet expedited shipping included with every plan.
- Ships from US-licensed 503A compounding pharmacies (Hallandale, VialsRx) to all 50 states.
- A refund policy is linked in the footer but details were not shown.
- Advertises 24/7 clinical support.
Cora Health customer support
- Phone
- (631) 488-0789
- help@trycora.io
- Hours
- 24/7 clinical support
GLP-1 medications Cora Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often — check Cora Health's current pricing and active discounts before you decide.
What we like
- Two named 503A compounding pharmacy partners disclosed on first-party pages (Hallandale Pharmacy + VialsRx)
- Hallandale Pharmacy is PCAB-accredited and operating since 2003 (independently verified)
- LegitScript Certified (seal ID 49690100 in footer)
- Flat per-tier pricing — no dose-escalation surcharge
- Annual commitment delivers $99/mo semaglutide and $135/mo tirzepatide
- All 50 states with HSA/FSA accepted
- Wasef Health PC clinical group with named physicians (Wasef MD, Chen DO, Okafor MD)
- No FDA Warning Letters
Watch-outs
- Compounded medications are not FDA-approved and not therapeutically equivalent to Wegovy/Zepbound
- Leanio Health LLC has zero independent operating-history footprint (no BBB, no press, likely <12 months old)
- Lowest advertised prices require 12-month commitment with no partial refunds
- No brand-name Wegovy/Zepbound or oral GLP-1 (orforglipron/Rybelsus) options
- Founder names and funding undisclosed on site
- Wasef Health PC clinical group is third-party (not Cora-employed physicians)
The verdict: a flat-rate compounder that actually names its pharmacy
Cora Health is a direct-to-consumer telehealth brand selling compounded semaglutide and tirzepatide at flat per-tier prices, starting as low as $99 a month. Two things make it worth a serious look. First, the price you pay does not climb as your dose escalates — most compounders quietly raise your bill as you titrate up, and Cora does not. Second, it discloses the specific 503A pharmacies that fill its prescriptions by name, which is genuinely rare in this corner of the market. If you want the cheapest possible compounded GLP-1 and you are comfortable committing for a stretch, Cora is a real contender. The catch is that the company behind it is brand new, so you are trading a longer track record for a lower price.
How the pricing really works: pay less by committing longer
Cora's whole pricing model is built around the length of your commitment, not your dose. Every dose inside a given plan costs the same flat rate, so you never get surprised by a higher charge after a titration step. What changes the number is how many months you sign up for up front.
- Semaglutide runs from a monthly rate down to $99 a month if you commit to a full year.
- Tirzepatide sits a tier higher, from its monthly rate down to a low-three-figure rate on the annual plan.
- Three-month and six-month plans land in between, so you can split the difference without going all-in for twelve months.
The median compounded GLP-1 in our database runs around $169 a month, so Cora's annual semaglutide rate of $99 is well under the typical price — and a fraction of the over-a-thousand-dollars-a-month list price for brand-name injectables. There is no membership or platform fee layered on top, shipping is free, and HSA/FSA cards are accepted. The honest trade-off: the headline $99 only happens if you pay for a 12-month plan, and those annual plans do not offer partial refunds if you stop early. If you are not sure GLP-1s are right for you yet, start on a shorter plan and step up once you know the medication agrees with you.
The medications: compounded only, two molecules, no brand or pills
Cora offers compounded semaglutide (the molecule in Wegovy and Ozempic) and compounded tirzepatide (the molecule in Zepbound and Mounjaro), both as injectables. Your plan is genuinely all-inclusive: the medication, a consultation with a licensed provider, ongoing provider monitoring, and expedited shipping are bundled into the single price.
Be clear-eyed about what compounded means. These are not FDA-approved products and they are not rated as therapeutically equivalent to Wegovy or Zepbound — they are made-to-order by a compounding pharmacy under different rules than the branded drug. If you specifically want brand-name Wegovy or Zepbound, or an oral option like Rybelsus, Cora does not offer them. It is a compounded-injectable shop, full stop.
What sets Cora apart: it tells you which pharmacy fills your script
This is the real differentiator. Most compounding telehealth brands keep their pharmacy partners anonymous. Cora names two of them in plain text on its own homepage, FAQ, and About pages — and repeats them in its site's structured data. The headline partner is Hallandale Pharmacy (legally Pharmcore Inc.) in Fort Lauderdale, Florida, which is PCAB-accredited and has been operating since 2003. We independently confirmed that pharmacy's accreditation and address line up. Cora also lists a second US-licensed 503A pharmacy, VialsRx. On our latest check (July 2026) its website was live and identifies as a licensed compounding pharmacy — but we have not independently confirmed its 503A state license through a pharmacy-board registry, so treat this second partner as named and reachable rather than fully vouched.
On the clinical side, prescriptions are handled by Wasef Health PC, a third-party medical group in Pinellas Park, Florida. As of July 2026 its named physicians are Dr. Michael Wasef, MD (medical director), Dr. Ozita Cooper, MD, and Dr. Andrew Sakla, DO. Naming both the pharmacy and the prescribing physicians is more transparency than most low-cost compounders provide, and it is the main reason Cora clears the bar above the cheapest no-name operators.
Trust and safety: better disclosure than most, but a very young company
Cora carries a LegitScript certification (seal ID 49690100 in its footer), there are no FDA Warning Letters on file against the brand, its pharmacies, or its clinical group, and the medical oversight is named rather than hidden. Those are real positives. We rate it MEDIUM confidence under our scoring methodology — solid, but with caveats you should know.
- The operating company, Leanio Health LLC (dba Cora Health), has essentially no public footprint — no BBB profile, no press, no founder names — which strongly suggests it is less than a year old.
- The prescribing physicians work through a separate group, Wasef Health PC, rather than being Cora employees.
- The second pharmacy partner (VialsRx) has a live website but we did not independently verify its 503A state license through a pharmacy-board registry.
- The lowest prices lock you into a year with no partial refunds.
Who should choose Cora — and who should skip it
Choose Cora if you are confident you want a compounded GLP-1, you want the lowest realistic monthly cost, and you value knowing exactly which accredited pharmacy is filling your prescription. The flat per-dose pricing is especially friendly if you expect to titrate to a high dose, since your bill will not move.
Skip it if you want brand-name medication, an oral option, or the reassurance of an established company with years of reviews behind it. A brand-new operator means a thinner safety net if something goes wrong, and the annual-plan refund terms are unforgiving. More cautious buyers may prefer to test the waters on Cora's monthly plan before committing to a year.
Bottom line
Cora Health pairs aggressively low flat-rate pricing with something most budget compounders refuse to give you: the actual name of an accredited, long-established pharmacy and named prescribing doctors. That transparency is what earns it a place worth considering. Just go in knowing the company itself is new and unproven, the deepest discounts require a 12-month commitment you cannot easily unwind, and compounded medications are not the same as FDA-approved Wegovy or Zepbound. For a value-focused patient who understands those trade-offs, it is a credible pick at $99 a month.
Shopping around? Telos Rx ($49/month) and bmiMD ($99/month) are the nearest alternatives to Cora Health in our rankings.
The Bottom Line
Cora Health is one of the most affordable GLP-1 options on the market.
Ready to start with Cora Health?
Starting at $99/month. See current pricing and start your free consultation.
Cora Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Cora Health review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Cora Health's current pricing
Plans start at $99/month. Start your free consultation to check eligibility and today's price.